Drug Search Results
More Filters [+]

Arterolane

Alternative Names: arterolane, rbx-11160, rbx11160, rbx 11160
Latest Update: 2022-08-30
Latest Update Note: PubMed Publication

Product Description

Mechanisms of Action: PfATP6 Inhibitor

Novel Mechanism: Yes

Modality: Small Molecule

Route of Administration: Oral

FDA Designation: None *

Approval Status: Not Approved

Approved Countries: India

Approved Indications: None

Known Adverse Events: None

Company: University of Oxford
Company Location:
Company CEO:
Additonal Commercial Interests: None

Clinical Description

Map of Global Clinical Trials for Arterolane

Countries in Clinic:

Active Clinical Trial Count:

Highest Development Phases

Phase 3: Malaria, Falciparum

Trial

Phase

Trial Status

Disease

Primary Completion Date

Probability of Success

TACTKenya

P3

Completed

Malaria, Falciparum

2019-06-03

BAKMAL1501

P3

Withdrawn

Malaria, Falciparum

2017-06-01

RBx/MMV05-06

P2

Completed

Malaria, Falciparum

None

Recent News Events